Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03698877 · ClinicalTrials.gov registry record
Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.
A clinical trial, sponsored by The Rogosin Institute.
- Completed
- Registry status
- 79
- Enrollment target
NCT03698877 is a clinical trial that has completed, run by The Rogosin Institute. The registered enrollment target is 79 participants.
The verdict
NCT03698877 has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The study is being conducted to determine if the blood test Brain Natriuretic Protein (BNP) can demonstrate the presence of extra fluid in patients with chronic kidney disease treated by hemodialysis. It will also try to determine the blood test Procalcitonin (PCT) can help identify the cause of the fever, specifically if a fever is caused by a bacterial infection. It will also evaluate whether new blood tests in the future (such as DNA, RNA, metabolite, and protein based tests) can be developed to help predict other complications in patients with chronic kidney disease treated by hemodialysis.
Interventions
- DIAGNOSTIC_TEST Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-12-26 |
| Est. Completion | 2022-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03698877
The ClinicalTrials.gov registry entry for NCT03698877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests is the first listed.
NCT03698877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03698877 about?
NCT03698877 is a clinical study titled "Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.". The study is being conducted to determine if the blood test Brain Natriuretic Protein (BNP) can demonstrate the presence of extra fluid in patients with chronic kidney disease treated by hemodialysis. It will also try to determine the blood test Procalcitonin (PCT) can help identify the cause of the...
What is the current status of trial NCT03698877?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2018-12-26. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT03698877?
The interventions under investigation include: Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03698877?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.